Cite
MLA Citation
Nicholas D James et al.. “Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.” Lancet, vol. 387, no. 10024, 2016, pp. 1163–1177. http://access.bl.uk/ark:/81055/vdc_100031152364.0x00001c